Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases.

Multiple Sclerosis and Related Disorders(2020)

引用 3|浏览3
暂无评分
摘要
•Autoimmune hemophilia A (AHA) or acquired hemophilia is a potentially fatal bleeding disorder•AHA may occur after the use of alemtuzumab (ALZ)•Vitiligo is an autoimmune disease mediated by autoantibodies against melanocytes•Vitiligo may occur or worsen after ALZ therapy
更多
查看译文
关键词
Acquired hemophilia A,Vitiligo,Autoimmune diseases,Alemtuzumab,Multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要